Quantifying Cost-Effectiveness of Controlling Nosocomial Spread of Antibiotic-Resistant Bacteria: The Case of MRSA
Marjan W. M. Wassenberg, G. Ardine de Wit, Ben A. van Hout et al. · 2010
Read Quantifying Cost-Effectiveness of Controlling Nosocomial Spread of Antibiotic-Resistant Bacteria: The Case of MRSA by Marjan W. M. Wassenberg, G. Ardine de Wit, Ben A. van Hout et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011562.txt.
Description
Marjan Wassenberg and co-authors priced hospital infection control in 2010 against the harm it prevents. MRSA, the drug-resistant staph germ, spreads between hospital patients, and hospitals deploy screening, isolation, and cleaning programs that cost real money. Managers asked to fund them need to know which measures pay for themselves in infections averted and which cost more than the damage they stop.
Their analysis quantified the cost-effectiveness of controlling nosocomial, or hospital-acquired, spread of resistant bacteria, using MRSA as the case. Putting numbers on both sides turns an argument about caution into an argument about value. Infection control often wins such comparisons once outbreak costs are counted honestly. The study gives hospital boards the arithmetic to defend budgets that look like pure cost until the infections that did not happen are priced in.
Catalog record
| CREATOR | Marjan W. M. Wassenberg, G. Ardine de Wit, Ben A. van Hout et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011562